AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating the Grey Market of Bioregulators and Affordability in Healthcare
This chapter explores the burgeoning business of bioregulators and peptides, addressing the ethical challenges doctors face in offering affordable treatment. It also delves into the implications of potential FDA regulations and the efforts of some practitioners to educate patients about self-administration to lower costs.